share_log

Pfizer | 8-K: Cyrus Taraporevala Elected to Pfizer's Board of Directors

Pfizer | 8-K: Cyrus Taraporevala Elected to Pfizer's Board of Directors

辉瑞 | 8-K：Cyrus Taraporevala当选为辉瑞董事会成员
美股sec公告 ·  07/01 08:08
Moomoo AI 已提取核心信息
On June 27, 2024, Pfizer Inc. announced the appointment of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, with a rich background in investment management and financial markets, has previously held the position of President and CEO at State Street Global Advisors and has served in leadership roles at various other financial institutions. His election to the Board also includes appointments to the Audit Committee and the Compensation Committee. Pfizer's Chairman and CEO, Albert Bourla, expressed confidence in Taraporevala's vast experience, which he believes will be an asset to Pfizer and its shareholders. The company highlighted Taraporevala's global operational experience and leadership as key factors that will contribute to Pfizer's mission of delivering breakthroughs that change patients' lives. The formal announcement was made through a press release dated July 1, 2024.
On June 27, 2024, Pfizer Inc. announced the appointment of Cyrus Taraporevala to its Board of Directors, effective immediately. Taraporevala, with a rich background in investment management and financial markets, has previously held the position of President and CEO at State Street Global Advisors and has served in leadership roles at various other financial institutions. His election to the Board also includes appointments to the Audit Committee and the Compensation Committee. Pfizer's Chairman and CEO, Albert Bourla, expressed confidence in Taraporevala's vast experience, which he believes will be an asset to Pfizer and its shareholders. The company highlighted Taraporevala's global operational experience and leadership as key factors that will contribute to Pfizer's mission of delivering breakthroughs that change patients' lives. The formal announcement was made through a press release dated July 1, 2024.
辉瑞公司于2024年6月27日宣布任命Cyrus Taraporevala为其董事会成员，立即生效。拥有丰富的投资管理和金融市场背景的Taraporevala曾担任State Street Global Advisors总裁和首席执行官，并在其他金融机构担任领导职务。他的董事会选举还包括被任命为审计委员会和薪酬委员会成员。辉瑞公司董事长兼首席执行官Albert Bourla对Taraporevala的丰富经验表示信恳智能，并认为他将成为辉瑞和其股东的资产。公司强调Taraporevala的全球运营经验和领导力是有助于实现辉瑞改变患者生命的突破性发展任务的关键因素之一。正式公告发表于2024年7月1日的新闻发布会上。
辉瑞公司于2024年6月27日宣布任命Cyrus Taraporevala为其董事会成员，立即生效。拥有丰富的投资管理和金融市场背景的Taraporevala曾担任State Street Global Advisors总裁和首席执行官，并在其他金融机构担任领导职务。他的董事会选举还包括被任命为审计委员会和薪酬委员会成员。辉瑞公司董事长兼首席执行官Albert Bourla对Taraporevala的丰富经验表示信恳智能，并认为他将成为辉瑞和其股东的资产。公司强调Taraporevala的全球运营经验和领导力是有助于实现辉瑞改变患者生命的突破性发展任务的关键因素之一。正式公告发表于2024年7月1日的新闻发布会上。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息